Why the study?
Does older age increase the risk of over-anticoagulation during induction and maintenance of warfarin therapy?
Does older age increase the risk of over-anticoagulation during induction and maintenance of warfarin therapy?
Older patients are at higher risk of over-anticoagulation with warfarin, suggesting that standard loading doses may be inappropriate and require age-adjusted protocols.
Answers are grounded in this paper and cite their sources.
Older age linked to higher warfarin over-anticoagulation risk; leaves open whether age-adjusted induction protocols improve safety.
We aimed to examine the effect of age upon the control of anticoagulation with warfarin in ordinary clinical practice, using a retrospective examination of routine anticoagulation clinic records from the University Hospital, Nottingham. Considerable over-anticoagulation (international normalisation ratio (INR) > 6.0) during induction occurred in 54 (11%) of 495 patients and was more likely in older patients (p < 0.05). Lesser degrees of over-anticoagulation during induction (INR > 4.0) were also more common in older patients, occurring in 58% of those aged 75 or above. Loading doses of warfarin were not reduced in older patients. INR in the maintenance phase rose with age (p < 0.001) despite lower maintenance doses of warfarin (p < 0.001). An INR > 6.0 in the maintenance phase was noted in 24 (3%) of 739 patients and again was more likely in older patients (p < 0.05). Patients using ambulance transport to the clinic were older than those who did not (p < 0.01) and those aged over 75 had shorter intervals between clinic visits (p < 0.01). We conclude that doctors using warfarin therapy do not take sufficient account of the increased sensitivity of older people to warfarin. Hospital anticoagulant policies need implementation and evaluation.
No takes yet. Share an insight, caveat, or question.
Gladman et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: